to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia

Abroad (travel likely)RecruitingPHASE3

Conditions

Menorrhagia · Uterine Fibroids

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Asan Medical Center, Seoul, South Korea
Contact: Study coordinator (Jeong Yeol Park) · 02-3010-3629

Study leads

Jeong Yeol Park
Principal Investigator
Asan Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia

Uterine Fibroids With Menorrhagia

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Heavy Menstrual Bleeding · Uterine Fibroids

Abroad (travel likely)RecruitingPHASE3

Beijing, China

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids · Endometriosis

Abroad (travel likely)RecruitingPHASE3

Mobile, United States · Chandler, United States

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension · Urinary Tract Infections in Children

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States